Status:
NOT_YET_RECRUITING
Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Nuclear Medicine
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
This single-center prospective observational study aims to evaluate the feasibility, cost-effectiveness, and clinical value of positron emission tomography/magnetic resonance imaging (PET/MRI) for ini...
Detailed Description
1. Background: Nasopharyngeal carcinoma (NPC) is prevalent in Southeast Asia and North Africa, with 5% of newly diagnosed cases showing distant metastases. For N2-3 stage patients with high Epstei...
Eligibility Criteria
Inclusion
- Pathologically diagnosed with nasopharyngeal carcinoma (NPC) through endoscopic biopsy at the hospital's otolaryngology department.
- Clinically staged as cT3-4/N2-N3.
- Age: 18 years and older.
- Participants must voluntarily sign an informed consent form, acknowledging understanding of the study objectives and potential risks.
Exclusion
- Patients with poorly controlled diabetes. -Patients with a history of head and neck malignancies or a history of non- head and neck cancers with no evidence of disease for at least 3 years.
- Patients with clinical staging of cT1-2N0-1.
- Patients with factors that may affect PET/MRI image quality, such as implanted metal devices or MRI contraindications, or those with a history of contrast agent allergies.
Key Trial Info
Start Date :
April 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06947759
Start Date
April 30 2025
End Date
April 30 2026
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan